- P/E Ratio
- 16.30
- Earnings
- $11.70M
- Price change (1 year)
- +40.86%
- Price change (1 day)
- -0.96%
DAROPharmaceutical Substances and Products
Market Capitalization of Daroupakhsh
Market capitalization (market cap): 192.74 million US dollars
The latest available market capitalization of Daroupakhsh (DARO), an Iranian listed company, is 192.74 million US dollars. Daroupakhsh ranks 90 by market capitalization among the Iranian listed companies.
Market capitalization is the market value of a listed company's outstanding shares. It measures equity value, not revenue, total assets, or enterprise value. Changes in market cap are not stock returns: they also reflect changes in share count and the exchange rate.
Daroupakhsh ranks 4 by market capitalization in Iran's Pharmaceutical Substances and Products sector among the listed companies by this site; this sector ranking covers 49 listed companies. Daroupakhsh represents approximately 5.67% of the total market capitalization of companies in Iran's Pharmaceutical Substances and Products sector. Over the past year, the market cap of Daroupakhsh has increased by 31.86%, with 46.75 million US dollars added to its market cap. According to the Daroupakhsh’s announcement, company’s annual profit is 11.70 million US dollars. Using the latest available data, the P/E ratio of Daroupakhsh is 16.3.
Daroupakhsh Market-Cap History
The latest recorded market capitalization of Daroupakhsh was 193.48 million US dollars on 1 November 2026. Over the full period of available data, this company's market cap has decreased by 48.63%, with approximately 183.16 million US dollars removed from its market cap.
Latest Market Cap by Year
| Year | Market cap | Change |
|---|---|---|
| 2026 | $193.48M | ▲ 6.44% |
| 2025 | $181.78M | ▲ 24.41% |
| 2024 | $146.11M | ▼ 55.15% |
| 2023 | $325.75M | ▼ 7.33% |
| 2022 | $351.53M | ▼ 11.46% |
| 2021 | $397.01M | ▼ 0.98% |
| 2020 | $400.95M | ▲ 30.94% |
| 2019 | $306.21M | ▲ 267.23% |
| 2018 | $83.38M | ▼ 57.31% |
| 2017 | $195.35M | ▼ 34.28% |
| 2016 | $297.26M | ▲ 9.68% |
| 2015 | $271.02M | ▲ 3.27% |
| 2014 | $262.43M | ▼ 35.6% |
| 2013 | $407.49M | ▲ 216.25% |
| 2012 | $128.85M | ▼ 57.95% |
| 2011 | $306.45M | — |
Other Companies in the Pharmaceutical Substances and Products sector
| Sector rank / Ticker / Company | Market cap | Price | Price change (1 day) |
|---|---|---|---|
| 1 ABDI Dr. Abidi Lab. | $482.32M | $0.008613 | -2.49% |
| 2 DTIP Tamin Daroo | $349.15M | $0.0109 | -2.21% |
| 3 DPAK Daroupakhsh P. | $213.75M | $0.004127 | +2.71% |
| 5 FTIR Iran Parenteral | $150.31M | $0.0215 | +0.42% |
| 6 DPHZ Daana Pharma Co | $124.98M | $0.008679 | -2.58% |